Nath Bio-Genes Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'13
Mar'12
No of Months
12
12
12
12
12
12
Profit Before Tax
40.00
41.00
36.00
-63.00
12.30
0.00
Adjustment
13.00
10.00
12.00
102.00
8.18
0.00
Changes In working Capital
-34.00
23.00
-9.00
-18.00
-5.72
0.00
Cash Flow after changes in Working Capital
18.00
74.00
39.00
19.00
14.76
0.00
Cash Flow from Operating Activities
17.00
74.00
38.00
17.00
14.21
0.00
Cash Flow from Investing Activities
-3.00
-27.00
-2.00
-19.00
-20.77
0.00
Cash Flow from Financing Activities
-2.00
-7.00
-1.00
-22.00
5.74
0.00
Net Cash Inflow / Outflow
11.00
39.00
33.00
-25.00
-0.81
0.00
Opening Cash & Cash Equivalents
77.00
38.00
4.00
29.00
3.29
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
88.00
77.00
38.00
4.00
2.48
0.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Nath Bio-Genes
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
44.12
9.33
35.00
372.88%
Adjustment
12.17
3.17
9.00
283.91%
Changes In working Capital
-28.41
-14.54
-14.00
-95.39%
Cash Flow after changes in Working Capital
27.88
-2.04
29.00
1466.67%
Cash Flow from Operating Activities
26.8
-4.31
30.00
721.81%
Cash Flow from Investing Activities
-4.05
-3.43
-1.00
-18.08%
Cash Flow from Financing Activities
-10.62
6.98
-16.00
-252.15%
Net Cash Inflow / Outflow
12.13
-0.77
12.00
1675.32%
Opening Cash & Cash Equivalents
75.5
0.88
75.00
8479.55%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
87.63
0.11
87.00
79563.64%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -76.43% vs 94.40% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
17.58
74.59
-76.43%






